Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: Analyses of the Quebec Family Study

Sleep Medicine

Volumn 10, Issue 8, 2009, Pages 919-924

  Chaput, Jean Philippe ^a   Després, Jean Pierre ^b   Bouchard, Claude ^c   Astrup, Arne ^d   Tremblay, Angelo ^a  

^a Faculty of Medicine   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glucose homeostasis; Metabolism; Prospective study; Sleep loss; Sleep time

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CANADA; CONTROLLED STUDY; DATA ANALYSIS; DIABETOGENESIS; DISEASE ASSOCIATION; FAMILY STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; SELF REPORT; SLEEP TIME; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN; MALE; MIDDLE AGED; QUEBEC; RISK FACTORS; SLEEP; SLEEP DISORDERS; YOUNG ADULT;

EID: 68249121136     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.09.016     Document Type: Article

References (38)

1. Amos A.F., McCarty D.J., and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14 Suppl 5 (1997) S1-S85
2. Kripke D., Simons R., Garkinkel L., and Hammond E. Short and long sleep and sleeping pills. Is increased mortality associated?. Arch Gen Psychiatry 36 (1979) 103-116
3. Gallup Organization. Sleep in America. Princeton, NJ: Gallup Organization; 1995.
4. National Center for Health Statistics. QuickStats: percentage of adults who reported an average of ≤6 h of sleep per 24-h period, by sex and age group - United States, 1985 and 2004. Morbidity and Mortality Weekly Report, 2005.
5. In: Chokroverty S. (Ed). Sleep disorders medicine: basic science, technical considerations, and clinical aspects. 2nd ed. (1999), Butterworth and Heinemann, Boston, MA 14-16
6. VanHelder T., Symons J.D., and Radomski M.W. Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med 64 (1993) 487-492
7. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
8. Spiegel K., Knutson K., Leproult R., Tasali E., and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 99 (2005) 2008-2019
9. Ayas N.T., White D.P., Al-Delaimy W.K., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26 (2003) 380-384
10. Mallon L., Broman J.E., and Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 28 (2005) 2762-2767
11. Yaggi H.K., Araujo A.B., and McKinlay J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29 (2006) 657-661
12. Irwin M., Thompson J., Miller C., Gillin J.C., and Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 84 (1999) 1979-1985
13. Tochikubo O., Ikeda A., Miyajima E., and Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 27 (1996) 1318-1324
14. Leproult R., Copinschi G., Buxton O., and Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20 (1997) 865-870
15. Chaput J.P., Després J.P., Bouchard C., and Tremblay A. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 50 (2007) 2298-2304
16. Mayer J. Glucostatic mechanism of regulation of food intake. N Engl J Med 249 (1953) 13-16
17. Bouchard C. Genetic and body fat content. Prog Obes Res 5 (1996) 33-41
18. The Airlie (VA) Consensus Conference. Standardization of anthropometric measurements. Champaign, IL: Human Kinetics Publishers; 1988.
19. Behnke A.R., and Wilmore J.H. Evaluation and regulation of body build and composition. In: Behnke A.R. (Ed). Evaluation and regulation of body build and composition (1974), Prentice-Hall, Englewood Cliffs, NJ 20-37
20. Meneely G.R., and Kaltreider N.L. Volume of the lung determined by helium dilution. J Clin Invest 28 (1949) 129-139
21. Siri W.E. The gross composition of the body. Adv Biol Med Phys 4 (1956) 239-280
22. Richterich R., and Dauwwalder H. Zur bestimmung der plasmaglukose-konzentration mit der hexokinase-glucose-6-phosphat-deshydrogenase-methode. Schweiz Med Wochenschr 101 (1971) 615-618
23. Desbuquois B., and Aurbach G.D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 37 (1971) 732-738
24. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
26. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
27. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 30 (2007) 1667-1673
28. Taheri S., Lin L., Austin D., Young T., and Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1 (2004) 210-217
29. Chaput J.P., Després J.P., Bouchard C., and Tremblay A. The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep 31 (2008) 517-523
30. Ayas N.T., White D.P., Manson J.E., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163 (2003) 205-209
31. Tamakoshi A., Ohno O., and JACC Study Group. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 27 (2004) 51-54
32. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
33. Greenberg A.S., and McDaniel M.L. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 Suppl 3 (2002) 24-34
34. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15 (2004) 2792-2800
35. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 26 (2003) 702-709
36. Tuomilehto H., Peltonen M., Partinen M., et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - the FIN-D2D survey. Sleep Med 9 (2008) 221-227
37. Lockley S.W., Skene D.J., and Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 8 (1999) 175-183
38. Hauri P.J., and Wisbey J. Wrist actigraphy in insomnia. Sleep 15 (1992) 293-301